XML 20 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
shares in Thousands, $ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Net investment in sales-type leases, allowances $ 465 $ 0
Ground Lease receivables, allowances 369 $ 0
Loans receivable, net - related party, allowances $ 2,429  
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 400,000 400,000
Common stock, shares issued (in shares) 71,077 62,397
Common stock, shares outstanding (in shares) 71,066 62,397
Deferred expenses and other assets, net [1],[2] $ 89,238 $ 67,564
Accounts payable, accrued expenses and other liabilities [2],[3] 134,518 100,357
Related party    
Deferred expenses and other assets, net $ 7,100  
Accounts payable, accrued expenses and other liabilities   $ 8,500
[1] As of December 31, 2023, includes $7.1 million due from related parties.
[2] Refer to Note 2 for details on the Company’s consolidated variable interest entities ("VIEs").
[3] As of December 31, 2022, includes $8.5 million due to related parties.